First-In-Human Phase I Trial Of Anti-Hepatocyte Growth Factor (Hgf) Antibody (Yyb101) In Refractory Solid Tumor Patients

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 9|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要